An overview of chagasic cardiomyopathy: pathogenic importance of oxidative stress

ALARCON-CORREDOR OM, 2002, Serum enzyme pattern and local enzyme gradients in chronic chagasic patients., Acta Cient Venez, 53, 210

ALIBERTI JC, 1996, Interleukin-12 mediates resistance to Trypanosoma cruzi in mice and is produced by murine macrophages in response to live trypomastigotes., Infect Immun, 64, 1961, 10.1128/IAI.64.6.1961-1967.1996

ALIBERTI JC, 2001, Modulation of chemokine production and inflammatory responses in interferon-gamma- and tumor necrosis factor-R1-deficient mice during Trypanosoma cruzi infection., Am J Pathol, 158, 1433, 10.1016/S0002-9440(10)64094-1

ANDRADE SG, 1992, Specific chemotherapy of Chagas disease: a comparison between the response in patients and experimental animals inoculated with the same strains., Trans R Soc Trop Med Hyg, 86, 624, 10.1016/0035-9203(92)90156-7

ANDREW PJ, 1999, Enzymatic function of nitric oxide synthases., Cardiovasc Res, 43, 521, 10.1016/S0008-6363(99)00115-7

BABIOR BM, 1999, NADPH oxidase: an update., Blood, 93, 1464, 10.1182/blood.V93.5.1464

BACHMAIER K, 1997, iNOS expression and nitrotyrosine formation in the myocardium in response to inflammation is controlled by the interferon regulatory transcription factor 1., Circulation, 96, 585

BAHIA-OLIVEIRA LM, 1998, IFN-gamma in human Chagas' disease: protection or pathology?, Braz J Med Biol Res, 31, 127, 10.1590/S0100-879X1998000100017

BEARD CB, 2003, Chagas disease in a domestic transmission cycle, southern Texas, USA., Emerg Infect Dis, 9, 103, 10.3201/eid0901.020217

BENIT P, 2001, Large-scale deletion and point mutations of the nuclear NDUFV1 and NDUFS1genes in mitochondrial complex I deficiency., Am J Hum Genet, 68, 1344, 10.1086/320603

BERRY CE, 2004, Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications, J Physiol, 555, 589, 10.1113/jphysiol.2003.055913

BRADLEY KK, 2000, Prevalence of American trypanosomiasis (Chagas disease) among dogs in Oklahoma, J Am Vet Med Assoc, 217, 1853, 10.2460/javma.2000.217.1853

BRENER Z, 1997, Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas' disease., Int Arch Allergy Immunol, 114, 103, 10.1159/000237653

BURLEIGH BA, 1995, The mechanisms of Trypanosoma cruzi invasion of mammalian cells., Annu Rev Microbiol, 49, 175, 10.1146/annurev.mi.49.100195.001135

BUTTERFIELD DA, 1998, Structural and functional changes in proteins induced by free radical-mediated oxidative stress and protective action of the antioxidants N - tert - butyl - alpha - phenylnitrone and vitamin E., Ann N Y Acad Sci, 854, 448, 10.1111/j.1749-6632.1998.tb09924.x

CANDEIAS LP, 1993, Free hydroxyl radicals are formed on reaction between the neutrophil-derived species superoxide anion and hypochlorous acid., FEBS Lett, 333, 151, 10.1016/0014-5793(93)80394-A

CARDOSO SM, 1999, Mitochondrial function is differentially affected upon oxidative stress., Free Radic Biol Med, 26, 3, 10.1016/S0891-5849(98)00205-6

CARRASCO GUERRA HA, 1987, Clinical, histochemical, and ultrastructural correlation in septal endomyocardial biopsies from chronic chagasic patients: detection of early myocardial damage., Am Heart J, 113, 716, 10.1016/0002-8703(87)90712-5

CARRASCO HA, 1997, Biochemical characterization of myocardial damage in chronic Chagas' disease, Clin Cardiol, 20, 865, 10.1002/clc.4960201013

CARROLL J, 2003, Analysis of the subunit composition of complex I from bovine heart mitochondria., Mol Cell Proteomics, 2, 117, 10.1074/mcp.M300014-MCP200

CHANDRA M, 2002, Significance of inducible nitric oxide synthase in acute myocarditis caused by Trypanosoma cruzi (Tulahuen strain)., Int J Parasitol, 32, 897, 10.1016/S0020-7519(02)00028-0

CHEN Q, 2003, Production of reactive oxygen species by mitochondria: Central role of complex III., J Biol Chem, 278, 36027, 10.1074/jbc.M304854200

CHEVION M, 2000, Human studies related to protein oxidation: protein carbonyl content as a marker of damage, Free Radic Res, 33, S99

COON MJ, 1992, Cytochrome P450: progress and predictions, Faseb J, 6, 669, 10.1096/fasebj.6.2.1537454

CORREA-OLIVEIRA R, 1999, The role of the immune response on the development of severe clinical forms of human Chagas disease., Mem Inst Oswaldo Cruz, 94, 253, 10.1590/S0074-02761999000700042

CROSS AR, 1994, The superoxide-generating system of human neutrophils possesses a novel diaphorase activity: Evidence for distinct regulation of electron flow within NADPH oxidase by p67-phox and p47-phox, J Biol Chem, 269, 21448, 10.1016/S0021-9258(17)31824-0

DALLE-DONNE I, 2003, Protein carbonylation in human diseases., Trends Mol Med, 9, 169, 10.1016/S1471-4914(03)00031-5

D'ALMEIDA P, 1996, Long-term evaluation of kidney donors, Transplant Proc, 28, 93

DE SOUZA AP, 2002, Trypanosoma cruzi: host selenium deficiency leads to higher mortality but similar parasitemia in mice., Exp Parasitol, 101, 193, 10.1016/S0014-4894(02)00134-0

DE SOUZA AP, 2003, Selenium supplementation at low doses contributes to the decrease in heart damage in experimental Trypanosoma cruzi infection., Parasitol Res, 91, 51, 10.1007/s00436-003-0867-9

DODD RY, 2004, Emerging infectious threats to the blood supply., Annu Rev Med, 55, 191, 10.1146/annurev.med.55.091902.103831

DROGE W., 2002, Free radicals in the physiological control of cell function., Physiol Rev, 82, 47, 10.1152/physrev.00018.2001

EISERICH JP, 2002, Myeloperoxidase, a leukocyte-derived vascular NO oxidase, Science, 296, 2391, 10.1126/science.1106830

ELIZARI MV, 2002, Arrhythmias associated with Chagas' heart disease., Card Electrophysiol Rev, 6, 115, 10.1023/A:1017911911178

ESTERBAUER H., 1982, Aldehydic producs of lipid peoxidation., 101

EVANS MD, 2004, Factors contributing to the outcome of oxidative damage to nucleic acids, Bioessays, 26, 533, 10.1002/bies.20027

FINKEL T., 2003, Oxidant signals and oxidative stress., Curr Opin Cell Biol, 15, 247, 10.1016/S0955-0674(03)00002-4

FLOYD RA, 2001, Oxidative biochemical markers; clues to understanding aging in long-lived species, Exp Gerontol, 36, 619, 10.1016/S0531-5565(00)00231-X

FRIDOVICH I., 1974, Superoxide dismutases., Adv Enzymol Relat Areas Mol Biol, 41, 35, 10.1002/9780470122860.ch2

GARG N, 2002, Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection., Infect Immun, 70, 5547, 10.1128/IAI.70.10.5547-5555.2002

GARG N, 1997, Delivery by Trypanosoma cruzi of proteins into the MHC class I antigen processing and presentation pathway., J Immunol, 158, 3293, 10.4049/jimmunol.158.7.3293

GARG N, 2003, Profiling gene transcription reveals a deficiency of mitochondrial oxidative phosphorylation in Trypanosoma cruzi-infected murine hearts: implications in chagasic myocarditis development., Biochim Biophys Acta, 1638, 106, 10.1016/S0925-4439(03)00060-7

GARG N, 2004, Gene expression analysis in mitochondria from chagasic mice: Alterations in specific metabolic pathways, Biochemical J, 381, 743, 10.1042/BJ20040356

GAZZINELLI RT, 1992, The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-beta., Eur J Immunol, 22, 2501, 10.1002/eji.1830221006

GOLDSTEIN S, 1993, The Fenton reagents, Free Radic Biol Med, 15, 435, 10.1016/0891-5849(93)90043-T

GOMEZ RM, 2002, Host selenium deficiency increases the severity of chronic inflammatory myopathy in Trypanosoma cruzi-inoculated mice., J Parasitol, 88, 541, 10.1645/0022-3395(2002)088[0541:HSDITS]2.0.CO;2

GUZMAN B., 2001, Epidemiology of Chagas disease in Mexico: an update, Trends Parasitol, 17, 372, 10.1016/S1471-4922(01)01952-3

HALLIWELL B., 1991, Reactive oxygen species in living systems: source, biochemistry, and role in human disease., Am J Med, 91, 14S, 10.1016/0002-9343(91)90279-7

HAN D, 2001, Mitochondrial respiratory chain-dependent generation of superoxide anion and its release into the intermembrane space, Biochem J, 353, 411, 10.1042/bj3530411

HAN D, 2003, Effect of glutathione depletion on sites and topology of superoxide and hydrogen peroxide production in mitochondria, Mol Pharmacol, 64, 1136, 10.1124/mol.64.5.1136

HAUPTMANN N, 1996, The metabolism of tyramine by monoamine oxidase A/B causes oxidative damage to mitochondrial DNA., Arch Biochem Biophys, 335, 295, 10.1006/abbi.1996.0510

HENSLEY K, 2000, Reactive oxygen species, cell signaling, and cell injury., Free Radic Biol Med, 28, 1456, 10.1016/S0891-5849(00)00252-5

HERWALDT BL, 2000, Use of polymerase chain reaction to diagnose the fifth reported US case of autochthonous transmission of Trypanosoma cruzi, in Tennessee, 1998., J Infect Dis, 181, 395, 10.1086/315212

HIGUCHI MD., 1995, Endomyocardial biopsy in Chagas' heart disease: pathogenetic contributions., São Paulo Med J, 113, 821, 10.1590/S1516-31801995000200013

HIGUCHI MD, 1997, Association of an increase in CD8+ T cells with the presence of Trypanosoma cruzi antigens in chronic, human, chagasic myocarditis., Am J Trop Med Hyg, 56, 485, 10.4269/ajtmh.1997.56.485

HIGUCHI M DE L, 2003, Pathophysiology of the heart in Chagas' disease: current status and new developments., Cardiovasc Res, 60, 96, 10.1016/S0008-6363(03)00361-4

HO YS, 1997, Mice deficient in cellular glutathione peroxidase develop normally and show no increased sensitivity to hyperoxia., J Biol Chem, 272, 16644, 10.1074/jbc.272.26.16644

HUANG H, 1999, Infection of endothelial cells with Trypanosoma cruzi activates NF-kappaB and induces vascular adhesion molecule expression., Infect Immun, 67, 5434, 10.1128/IAI.67.10.5434-5440.1999

IDE T, 1999, Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium, Circ Res, 85, 357, 10.1161/01.RES.85.4.357

IDE T, 2001, Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction., Circ Res, 88, 529, 10.1161/01.RES.88.5.529

IWATA S, 1998, Complete structure of the 11-subunit bovine mitochondrial cytochrome bc1 complex, Science, 281, 64, 10.1126/science.281.5373.64

JARDIM E, 1994, Chagasic meningoencephalitis with detection of Trypanosoma cruzi in the cerebrospinal fluid of an immunodepressed patient., J Trop Med Hyg, 97, 367

JONES EM, 1992, A Trypanosoma cruzi DNA sequence amplified from inflammatory lesions in human chagasic cardiomyopathy., Trans Assoc Am Physicians, 105, 182

JONES EM, 1993, Amplification of a Trypanosoma cruzi DNA sequence from inflammatory lesions in human chagasic cardiomyopathy., Am J Trop Med Hyg, 48, 348, 10.4269/ajtmh.1993.48.348

KANNO T, 2002, Mitochondrial swelling and cytochrome c release: sensitivity to cyclosporin A and calcium, Physiol Chem Phys Med NMR, 34, 91

KATSANOS KH, 2002, Alarming atrioventricular block and mitral valve prolapse in the Kearns-Sayre syndrome., Int J Cardiol, 83, 179, 10.1016/S0167-5273(02)00040-2

KIRKINEZOS IG, 2001, Reactive oxygen species and mitochondrial diseases, Semin Cell Dev Biol, 12, 449, 10.1006/scdb.2001.0282

KOBERLE F., 1968, Chagas' disease and Chagas' syndromes: the pathology of American trypanosomiasis., Adv Parasitol, 6, 63, 10.1016/S0065-308X(08)60472-8

KORGE P, 2001, Regulation of the mitochondrial permeability transition by matrix Ca(2+) and voltage during anoxia/reoxygenation., Am J Physiol Cell Physiol, 280, C517, 10.1152/ajpcell.2001.280.3.C517

KURIHARA H, 1989, Transforming growth factor-beta stimulates the expression of endothelin mRNA by vascular endothelial cells., Biochem Biophys Res Commun, 159, 1435, 10.1016/0006-291X(89)92270-5

LEIBY DA, 2000, Evidence of Trypanosoma cruzi infection (Chagas' disease) among patients undergoing cardiac surgery., Circulation, 102, 2978, 10.1161/01.CIR.102.24.2978

LEON JS, 2001, Cardiac myosin autoimmunity in acute Chagas' heart disease., Infect Immun, 69, 5643, 10.1128/IAI.69.9.5643-5649.2001

LESNEFSKY EJ, 2001, Ischemic injury to mitochondrial electrontransport in the aging heart: damage to the iron-sulfur protein subunit of electron transport complex III, Arch Biochem Biophys, 385, 117, 10.1006/abbi.2000.2066

LI Y, 1995, Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase, Nat Genet, 11, 376, 10.1038/ng1295-376

LIANG Q, 2002, Divergent signaling pathways converge on GATA4 to regulate cardiac hypertrophic gene expression., J Mol Cell Cardiol, 34, 611, 10.1006/jmcc.2002.2011

LOEFFEN J, 2001, Mutations in the complex I NDUFS2 gene of patients with cardiomyopathy and encephalomyopathy., Ann Neurol, 49, 195, 10.1002/1531-8249(20010201)49:2<195::AID-ANA39>3.0.CO;2-M

LOSCHEN G, 1971, Respiratory chain linked H(2)O(2) production in pigeon heart mitochondria., FEBS Lett, 18, 261, 10.1016/0014-5793(71)80459-3

MARIN-NETO JA, 1998, Cardiac dysautonomia and pathogenesis of Chagas' heart disease, Int J Cardiol, 66, 129

MARNETT LJ, 2000, Oxyradicals and DNA damage., Carcinogenesis, 21, 361, 10.1093/carcin/21.3.361

MARTINDALE JL, 2002, Cellular response to oxidative stress: signaling for suicide and survival, J Cell Physiol, 192, 1, 10.1002/jcp.10119

MARTINS GA, 1998, Nitric oxide-induced apoptotic cell death in the acute phase of Trypanosoma cruzi infection in mice., Immunol Lett, 63, 113, 10.1016/S0165-2478(98)00066-2

MCINTYRE M, 1999, Endothelial function in hypertension: the role of superoxide anion, Hypertension, 34, 539, 10.1161/01.HYP.34.4.539

MEDRANO CJ, 1994, Substrate-dependent effects of calcium on rat retinal mitochondrial respiration: physiological and toxicological studies, Toxicol Appl Pharmacol, 125, 309, 10.1006/taap.1994.1077

MEURS KM, 1998, Chronic Trypanosoma cruzi infection in dogs: 11 cases (1987-1996), J Am Vet Med Assoc, 213, 497, 10.2460/javma.1998.213.04.497

MILES M., 2003, American trypanosomiasis (Chagas disease), 2, 1325

MINOPRIO P, 1987, Suppression of polyclonal antibody production in Trypanosoma cruzi-infected mice by treatment with anti-L3T4 antibodies., J Immunol, 139, 545, 10.4049/jimmunol.139.2.545

MIYAUCHI T, 1999, Pathophysiology of endothelin in the cardiovascular system., Annu Rev Physiol, 61, 391, 10.1146/annurev.physiol.61.1.391

MONTEIRO FA, 2001, Molecular tools and triatomine systematics: a public health perspective, Trends Parasitol, 17, 344, 10.1016/S1471-4922(01)01921-3

MORTARA RA, 1999, Imaging Trypanosoma cruzi within tissues from chagasic patients using confocal microscopy with monoclonal antibodies., Parasitol Res, 85, 800, 10.1007/s004360050636

MOTT KE, 1965, The Pathologic Lesions of the Cardiac Autonomic Nervous System in Chronic Chagas' Myocarditis., Circulation, 31, 273, 10.1161/01.CIR.31.2.273

MOTT KE, 1978, House construction, triatomine distribution, and household distribution of seroreactivity to Trypanosoma cruzi in a rural community in northeast Brazil., Am J Trop Med Hyg, 27, 1116, 10.4269/ajtmh.1978.27.1116

MUKHERJEE S, 2003, Microarray analysis of changes in gene expression in a murine model of chronic chagasic cardiomyopathy., Parasitol Res, 91, 187, 10.1007/s00436-003-0937-z

MURRAY J, 2003, Oxidative damage to mitochondrial complex I due to peroxynitrite: identification of reactive tyrosines by mass spectrometry., J Biol Chem, 278, 37223, 10.1074/jbc.M305694200

NOGUEIRA N, 1978, Trypanosoma cruzi: in vitro induction of macrophage microbicidal activity., J Exp Med, 148, 288, 10.1084/jem.148.1.288

NORDBERG J, 2001, Reactive oxygen species, antioxidants, and the mammalian thioredoxin system., Free Radic Biol Med, 31, 1287

OCHS DE, 1996, Postmortem diagnosis of autochthonous acute chagasic myocarditis by polymerase chain reaction amplification of a species-specific DNA sequence of Trypanosoma cruzi., Am J Trop Med Hyg, 54, 526, 10.4269/ajtmh.1996.54.526

OLIVEIRA JS, 1985, A natural human model of intrinsic heart nervous system denervation: Chagas' cardiopathy, Am Heart J, 110, 1092, 10.1016/0002-8703(85)90222-4

PALACIOS-PRU E, 1989, Ultrastructural characteristics of different stages of human chagasic myocarditis, Am J Trop Med Hyg, 41, 29, 10.4269/ajtmh.1989.41.29

PALMEIRA CM, 1997, Preferential oxidation of cardiac mitochondrial DNA following acute intoxication with doxorubicin., Biochim Biophys Acta, 1321, 101, 10.1016/S0005-2728(97)00055-8

PAPA S, 2002, The NADH: ubiquinone oxidoreductase (complex I) of the mammalian respiratory chain and the cAMP cascade, J Bioenerg Biomembr, 34, 1, 10.1023/A:1013863018115

PARADA H, 1997, Cardiac involvement is a constant finding in acute Chagas' disease: a clinical, parasitological and histopathological study, Int J Cardiol, 60, 49, 10.1016/S0167-5273(97)02952-5

PEREZ-FUENTES R, 2003, Severity of chronic Chagas disease is associated with cytokine/antioxidant imbalance in chronically infected individuals, Int J Parasitol, 33, 293, 10.1016/S0020-7519(02)00283-7

PETKOVA SB, 2000, Cell cycle molecules and diseases of the cardiovascular system, Front Biosci, 5, D452, 10.2741/Petkova

PETKOVA SB, 2000, Myocardial expression of endothelin-1 in murine Trypanosoma cruzi infection., Cardiovasc Pathol, 9, 257, 10.1016/S1054-8807(00)00045-4

PETKOVA SB, 2001, The role of endothelin in the pathogenesis of Chagas' disease., Int J Parasitol, 31, 499, 10.1016/S0020-7519(01)00168-0

PIPER HM, 1994, Mitochondrial function in the oxygen depleted and reoxygenated myocardial cell., Cardiovasc Res, 28, 1, 10.1093/cvr/28.1.1

PONTES-DE-CARVALHO L, 2002, Experimental chronic Chagas' disease myocarditis is an autoimmune disease preventable by induction of immunological tolerance to myocardial antigens., J Autoimmun, 18, 131, 10.1006/jaut.2001.0574

RASSI JR A, 2000, Chagas' heart disease, Clin Cardiol, 23, 883, 10.1002/clc.4960231205

REIS MM, 1997, An in situ quantitative immunohistochemical study of cytokines and IL-2R+ in chronic human chagasic myocarditis: correlation with the presence of myocardial Trypanosoma cruzi antigens, Clin Immunol Immunopathol, 83, 165, 10.1006/clin.1997.4335

RIVERA MT, 2002, Progressive Chagas' cardiomyopathy is associated with low selenium levels., Am J Trop Med Hyg, 66, 706, 10.4269/ajtmh.2002.66.706

ROCHA A, 1994, Pathology of patients with Chagas' disease and acquired immunodeficiency syndrome., Am J Trop Med Hyg, 50, 261, 10.4269/ajtmh.1994.50.261

ROCHA MO, 2003, Clinical management of chronic Chagas cardiomyopathy, Front Biosci, 8, e44, 10.2741/926

ROSSI MA, 1996, Coronary microvascular abnormalities in Chagas' disease, Am Heart J, 132, 207, 10.1016/S0002-8703(96)90417-2

ROSSI MA, 2003, Chagas' heart disease: clinical-pathological correlation, Front Biosci, 8, e94, 10.2741/948

SALOMONE OA, 2000, Prevalence of circulating Trypanosoma cruzi detected by polymerase chain reaction in patients with Chagas' cardiomyopathy., Am J Cardiol, 85, 1274, 10.1016/S0002-9149(00)00747-5

SARTORI AM, 1995, Simultaneous occurrence ofacute myocarditis and reactivated Chagas' disease in a patient with AIDS., Clin Infect Dis, 21, 1297, 10.1093/clinids/21.5.1297

SATO W, 1993, Deletion of mitochondrial DNA in a patient with conduction block., Am Heart J, 125, 550, 10.1016/0002-8703(93)90046-C

SAWYER DB, 2002, Role of oxidative stress in myocardial hypertrophy and failure., J Mol Cell Cardiol, 34, 379, 10.1006/jmcc.2002.1526

SCHOFIELD CJ, 1999, The Southern Cone Initiative against Chagas disease., Adv Parasitol, 42, 1, 10.1016/S0065-308X(08)60147-5

SCHUELKE M, 1999, Mutant NDUFV1 subunit of mitochondrial complex I causes leukodystrophy and myoclonic epilepsy., Nat Genet, 21, 260, 10.1038/6772

SERRANO J, 1999, Cardioselective and cumulative oxidation of mitochondrial DNA following subchronic doxorubicin administration., Biochim Biophys Acta, 1411, 201, 10.1016/S0005-2728(99)00011-0

SOARES MB, 1999, Immunopathology of cardiomyopathy in the experimental Chagas disease, Mem Inst Oswaldo Cruz, 94, 257, 10.1590/S0074-02761999000700043

SOARES MB, 2001, The pathogenesis of Chagas' disease: when autoimmune and parasite-specific immune responses meet, An Acad Bras Cienc, 73, 547, 10.1590/S0001-37652001000400008

TANOWITZ HB, 1992, Cytokine gene expression of endothelial cells infected with Trypanosoma cruzi., J Infect Dis, 166, 598, 10.1093/infdis/166.3.598

TARLETON RL, 1990, Depletion of CD8+ T cells increases susceptibility and reverses vaccine-induced immunity in mice infected with Trypanosoma cruzi., J Immunol, 144, 717, 10.4049/jimmunol.144.2.717

TARLETON RL, 1992, Susceptibility of beta 2-microglobulin-deficient mice to Trypanosoma cruzi infection., Nature, 356, 338, 10.1038/356338a0

THOMSON SA, 1998, Delivery of multiple CD8 cytotoxic T cell epitopes by DNA vaccination., J Immunol, 160, 1717, 10.4049/jimmunol.160.4.1717

TOKORO T, 1996, Alterations in mitochondrial DNA and enzyme activities in hypertrophied myocardium of stroke-prone SHRS., Clin Exp Hypertens, 18, 595, 10.3109/10641969609081769

TORRICO F, 1991, Endogenous IFN-gamma is required for resistance to acute Trypanosoma cruzi infection in mice., J Immunol, 146, 3626, 10.4049/jimmunol.146.10.3626

TURRENS JF, 2003, Mitochondrial formation of reactive oxygen species., J Physiol, 552, 335, 10.1113/jphysiol.2003.049478

TURRENS JF., 2004, Oxidative stress and antioxidant defenses: a target for the treatment of diseases caused by parasitic protozoa, Mol Aspects Med, 25, 211, 10.1016/j.mam.2004.02.021

UCHIDA K, 1992, Modification of histidine residues in proteins by reaction with 4-hydroxynonenal., Proc Natl Acad Sci USA, 89, 4544, 10.1073/pnas.89.10.4544

UEDA S, 2002, Redox control of cell death, Antioxid Redox Signal, 4, 405, 10.1089/15230860260196209

UYEMURA SA, 1995, Energetics of heart mitochondria during acute phase of Trypanosoma cruzi infection in rats., Int J Biochem Cell Biol, 27, 1183, 10.1016/1357-2725(95)00073-X

VAN REMMEN H, 2001, Knockout mice heterozygous for Sod2 show alterations in cardiac mitochondrial function and apoptosis., Am J Physiol Heart Circ Physiol, 281, H1422, 10.1152/ajpheart.2001.281.3.H1422

VERCESI AE, 1997, The role of reactive oxygen species in mitochondrial permeability transition., Biosci Rep, 17, 43, 10.1023/A:1027335217774

VESPA GN, 1994, Nitric oxide is involved in control of Trypanosoma cruzi-induced parasitemia and directly kills the parasite in vitro., Infect Immun, 62, 5177, 10.1128/IAI.62.11.5177-5182.1994

VIOTTI R, 1994, Treatment of chronic Chagas' disease with benznidazole: clinical and serologic evolution of patients with long-term follow-up., Am Heart J, 127, 151, 10.1016/0002-8703(94)90521-5

VYATKINA G, 2004, Impaired mitochondrial respiratory chain and bioenergetics during chagasic cardiomyopathy development., Biochim Biophys Acta, 1689, 162, 10.1016/j.bbadis.2004.03.005

WALLACE DC., 2000, Mitochondrial defects in cardiomyopathy and neuromuscular disease., Am Heart J, 139, S70, 10.1067/mhj.2000.103934

WEN J-J, 2004, Oxidative modifications of mitochondrial respiratory complexes in response to the stress of Trypanosoma cruzi infection., Free Radic Biol Med, 37, 2072, 10.1016/j.freeradbiomed.2004.09.011

WEN J-J, 2004, Oxidative damage during chagasic cardiomyopathy development: Role of mitochondrial oxidant release and inefficient antioxidant defense., Free Radic Biol Med, 37, 1821, 10.1016/j.freeradbiomed.2004.08.018

WILLIAMS MD, 1998, Increased oxidative damage is correlated to altered mitochondrial function in heterozygous manganese superoxide dismutase knockout mice., J Biol Chem, 273, 28510, 10.1074/jbc.273.43.28510

WINTERBOURN CC, 2000, Myeloperoxidase, Curr Opin Hematol, 7, 53, 10.1097/00062752-200001000-00010

WITTNER M, 1995, Trypanosoma cruzi induces endothelin release from endothelial cells., J Infect Dis, 171, 493, 10.1093/infdis/171.2.493

WIZEL B, 1997, Identification of Trypanosoma cruzi trans-sialidase family members as targets of protective CD8+ TC1 responses., J Immunol, 159, 6120, 10.4049/jimmunol.159.12.6120

WIZEL B, 1998, Vaccination with trypomastigote surface antigen 1-encoding plasmid DNA confers protection against lethal Trypanosoma cruzi infection, Infect Immun, 66, 5073, 10.1128/IAI.66.11.5073-5081.1998

2002, Control of chagas disease: second report of the WHO expert committee Strategic Direction for Research., Geneva Switzerland, 1

YABSLEY MJ, 2002, Seroprevalence of Trypanosoma cruzi in raccoons from South Carolina and Georgia., J Wildl Dis, 38, 75, 10.7589/0090-3558-38.1.75

YANAGISAWA M, 1988, A novel potent vasoconstrictor peptide produced by vascular endothelial cells., Nature, 332, 411, 10.1038/332411a0

ZARKOVIC N., 2003, 4-Hydroxynonenal as a bioactive marker of pathophysiological processes., Mol Aspects Med, 24, 281, 10.1016/S0098-2997(03)00023-2